Jan Leppert
Overview
Explore the profile of Jan Leppert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
229
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuppler P, Ditz C, Kuchler J, Fieseler K, Kehler U, Leppert J
J Neurosurg Case Lessons
. 2025 Mar;
9(9).
PMID: 40030163
Background: Chronic negative-pressure hydrocephalus (cNegPH) is a rare condition, with only a few cases reported worldwide. Improvement of symptoms correlates with a reduction in ventricular size, which has been well...
2.
Finger A, Greinert F, Grohmann M, Seyedi N, Zohri R, Krull A, et al.
In Vivo
. 2024 Oct;
38(6):2795-2803.
PMID: 39477435
Background/aim: Xerostomia following (chemo-) radiotherapy (CRT) is common in head and neck (HNC) patients. This prospective study focused on investigating the link between salivary gland function and the onset of...
3.
Leppert J, Ditz C, Matschke J, Matone M, Kuppler P, Hillbricht C, et al.
Anticancer Res
. 2024 Oct;
44(11):5043-5049.
PMID: 39477314
Background/aim: Presurgical tumor volume progression in glioblastoma (GBM) may be a predictor of survival. This study aims to evaluate the potential impact of preoperative tumor growth and other clinical as...
4.
Leppert J, Ditz C, Grohmann M, Ziemann C, Hillbricht C, Liubich L, et al.
Anticancer Res
. 2024 Sep;
44(10):4403-4412.
PMID: 39348995
Background/aim: To investigate the significance of the timing of chemoradiotherapy together with clinical and laboratory features in newly diagnosed glioblastoma. Patients And Methods: Clinical and laboratory parameters of 209 patients...
5.
Rades D, Zemskova O, Leppert J, Yu N
Anticancer Res
. 2024 Aug;
44(9):3973-3981.
PMID: 39197927
Background/aim: The prognostic value of scoring instruments was described for newly diagnosed glioblastoma. This study investigated five instruments in patients with recurrent tumors. Patients And Methods: Original Glasgow Prognostic Score...
6.
Zemskova O, Yu N, Leppert J, Loser A, Rades D
In Vivo
. 2024 Aug;
38(5):2341-2348.
PMID: 39187342
Background/aim: In patients with recurrent glioblastoma, very little data are available regarding the prognostic value of platelet-to-lymphocyte (PLR) and neutrophil-to-lymphocyte (NLR) ratios. This study investigated potential associations between PLR or...
7.
Leppert J, Brehmer T, Boeker P, Wust M
J Sep Sci
. 2024 Aug;
47(16):e2400419.
PMID: 39178022
A general method for the calculation of the flow and pressure of a gas in a network of cylindrical capillaries is presented. This method is used specifically for gas chromatographic...
8.
Zemskova O, Yu N, Loser A, Leppert J, Rades D
Cancer Diagn Progn
. 2024 Jul;
4(4):408-415.
PMID: 38962535
Background/aim: Previous studies suggested pre-operative platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) to be predictive factors in patients with glioblastoma multiforme (GBM). This study investigated the prognostic role of PLR...
9.
Zemskova O, Yu N, Loser A, Leppert J, Rades D
In Vivo
. 2024 Jun;
38(4):1806-1813.
PMID: 38936935
Background/aim: Prognostic factors can facilitate treatment personalization in patients with glioblastoma multiforme (GBM). This study investigated different Glasgow prognostic scores (GPS) and the LabBM score in patients with GBM receiving...
10.
Zemskova O, Yu N, Leppert J, Rades D
Anticancer Res
. 2024 Jun;
44(7):3059-3066.
PMID: 38925836
Background/aim: Many patients with glioblastoma experience an intracerebral recurrence and require a personalized treatment. This study aimed to facilitate this approach by identifying prognostic factors for progression-free survival (PFS) and...